A Randomized Controlled Trial Comparing Platelet-Rich Plasma, Low-Level Laser Therapy, and Complex Decongestive Physiotherapy in Patients with Lower Limb Lymphedema

Akgul A., Tarakci E., Arman N., Civi T., Irmak S.

LYMPHATIC RESEARCH AND BIOLOGY, vol.18, pp.439-447, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

  • Nəşrin Növü: Article / Article
  • Cild: 18
  • Nəşr tarixi: 2020
  • Doi nömrəsi: 10.1089/lrb.2019.0064
  • jurnalın adı: LYMPHATIC RESEARCH AND BIOLOGY
  • Jurnalın baxıldığı indekslər: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE, MEDLINE
  • Səhifə sayı: pp.439-447
  • Açar sözlər: secondary lymphedema, platelet-rich plasma, low-level laser therapy, complex decongestive physiotherapy, QoL, MAST-CELLS, DEVICE, BLOOD, SKIN
  • Açıq Arxiv Kolleksiyası: Məqalə
  • Adres: Yox

Qısa məlumat

Background: Platelet-rich plasma (PRP) is an autologous concentrated preparation of platelets characterized by lymphangiogenetic and tissue-repairing effects. Although PRP has been safely used in many different fields, there is no clinical study regarding the use of PRP in lymphedema treatment in humans. We assessed the clinical outcomes of PRP in patients with lower extremity lymphedema (LEL) in a randomized controlled trial.